Search
for
Sort by
Research 301–330 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Guidelines for the Use of Acitretin in Psoriasis
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Alopecia Areata
- Hair Loss in Children
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms
- The Pathogenesis of Alopecia Areata in Rodent Models
- Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature
- Late‐onset alopecia areata: A retrospective study of 73 patients from Taiwan
- Female Adolescent Hair Disorders
- Topical Mechlorethamine Restores Autoimmune-Arrested Follicular Activity in Mice with an Alopecia Areata-Like Disease by Targeting Infiltrated Lymphocytes
- Skin manifestations of chronic kidney disease
- Systemic causes of hair loss
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Platycarya strobilacea S. et Z. Extract Has a High Antioxidant Capacity and Exhibits Hair Growth-promoting Effects in Male C57BL/6 Mice
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication
- Update on the Treatment of Alopecia Areata
- Immunomodulators in the treatment of cutaneous lymphoma
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis